Goldman Sachs’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,275,449
Closed -$107M 6644
2025
Q2
$107M Buy
2,275,449
+1,649,354
+263% +$73.4M 0.02% 857
2025
Q1
$27.6M Buy
626,095
+286,178
+84% +$13.2M 0.01% 1722
2024
Q4
$12.3M Sell
339,917
-81,859
-19% -$2.86M ﹤0.01% 2599
2024
Q3
$13.5M Buy
421,776
+35,735
+9% +$1.34M ﹤0.01% 2426
2024
Q2
$14.5M Buy
386,041
+11,940
+3% +$503K ﹤0.01% 2151
2024
Q1
$18.4M Sell
374,101
-87,174
-19% -$4.03M ﹤0.01% 1908
2023
Q4
$16.8M Sell
461,275
-131,202
-22% -$3.42M ﹤0.01% 2064
2023
Q3
$13.7M Sell
592,477
-314,092
-35% -$8.59M ﹤0.01% 2119
2023
Q2
$23.8M Buy
906,569
+445,532
+97% +$11.7M 0.01% 1705
2023
Q1
$11.9M Buy
461,037
+78,849
+21% +$2.3M ﹤0.01% 2263
2022
Q4
$9.94M Sell
382,188
-103,165
-21% -$2.54M ﹤0.01% 2594
2022
Q3
$13.8M Buy
485,353
+214,666
+79% +$6.15M ﹤0.01% 2195
2022
Q2
$6.67M Buy
270,687
+47,978
+22% +$1.75M ﹤0.01% 2864
2022
Q1
$12.6M Buy
222,709
+402
+0.2% +$23K ﹤0.01% 2459
2021
Q4
$13.8M Buy
222,307
+4,944
+2% +$327K ﹤0.01% 2468
2021
Q3
$13.8M Buy
217,363
+31,610
+17% +$2.44M ﹤0.01% 2411
2021
Q2
$15.3M Buy
185,753
+45,766
+33% +$3.47M ﹤0.01% 2290
2021
Q1
$10.3M Sell
139,987
-206,017
-60% -$16.1M ﹤0.01% 2539
2020
Q4
$25.1M Buy
346,004
+337,123
+3,796% +$21.7M 0.01% 1665
2020
Q3
$423K Sell
8,881
-38,369
-81% -$1.63M ﹤0.01% 4569
2020
Q2
$1.99M Buy
+47,250
New +$1.68M ﹤0.01% 3463
2019
Q4
Sell
-50,760
Closed -$1.1M 5403
2019
Q3
$1.1M Buy
+50,760
New +$1.2M ﹤0.01% 3966

Other funds holding SWTX